Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-25-001476
Filing Date
2025-01-08
Accepted
2025-01-08 20:31:53
Documents
2
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1557
2 ex24.htm EX-24 8946
  Complete submission text file 0001493152-25-001476.txt   12195
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6209 WEDGEWOOD RD BETHESDA MD 20817
Business Address
Shojaei Amir (Reporting) CIK: 0002051427 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35814 | Film No.: 25519834